An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation show a high response to EGFR-tyrosine kinase inhibitor (EGFR-TKI). Clinically, EGFR-positive NSCLC acquires several resistance mechanisms during EGFR-TKI treatment, such as the emergence of a secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Akihiro, Uchino, Junji, Tanimura, Keiko, Chihara, Yusuke, Tamiya, Nobuyo, Kaneko, Yoshiko, Takeda, Takayuki, Hiranuma, Osamu, Hasegawa, Isao, Kubota, Yutaka, Shiotsu, Shinsuke, Takumi, Chieko, Hiraoka, Noriya, Yamada, Tadaaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200532/
https://www.ncbi.nlm.nih.gov/pubmed/30290647
http://dx.doi.org/10.1097/MD.0000000000012660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200532/
https://www.ncbi.nlm.nih.gov/pubmed/30290647
http://dx.doi.org/10.1097/MD.0000000000012660

Ejemplares similares